INVICTUS MD STRATEGIES CORP. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
Performance
| 1 day | -99.00% |
Volumes
marketsDaily volume
275 950
Estimated daily volume
349 947
Record volume 1
4 824 590
Record volume 2
2 305 687
Record volume 3
1 926 834
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
1 245
Net sales ()
5
Free-Float
6.83 %
Free-Float capitalization (USD)
8
Highs and lows
3 years
0.00
0.08
5 years
0.000.45
10 years
0.002.76
Indicators
Moving average 100 days
0.00
Price spread / (MMA100)
+9,900.00%
RSI 9 days
0.00
RSI 14 days
0.00
Sector Comparison - Alternative Medicine
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -99.00% | -.--% | - | - | 1.24K | ||
| -1.73% | -0.48% | +42.64% | +42.55% | 6.38B | ||
| -1.76% | +1.51% | -15.52% | -32.11% | 4.59B | ||
| -1.09% | +4.29% | +8.35% | -19.60% | 3.39B | ||
| -2.32% | -4.48% | -11.10% | +3.56% | 3.2B | ||
| -1.75% | -3.26% | -4.12% | -22.88% | 2.52B | ||
| -2.38% | -0.12% | +46.46% | +52.99% | 2B | ||
| -1.08% | -2.78% | -7.97% | -36.26% | 1.7B | ||
| -0.76% | -2.63% | -1.07% | -3.01% | 1.65B | ||
| -1.06% | -4.58% | -11.56% | -34.78% | 1.58B | ||
| -1.75% | -0.38% | +47.37% | +33.36% | 1.55B | ||
| 0.00% | -0.69% | +36.19% | -7.74% | 1.34B | ||
| -1.62% | -1.35% | +0.90% | -20.54% | 1.21B | ||
| +8.10% | +8.97% | +53.43% | +85.59% | 1.11B | ||
| -0.25% | -2.23% | -11.26% | -15.45% | 1.04B | ||
| -2.59% | -1.50% | -22.04% | -35.91% | 960M | ||
| Average | -6.97% | -0.44% | +10.05% | -0.68% | ||
| Weighted average by Cap. | -1.26% | -0.18% | +11.47% | +1.67% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2023 | -.--% | ||
| 2022 | -.--% | ||
| 2021 | -100.00% | ||
| 2020 | -72.49% | ||
| 2019 | -85.73% | ||
| 2018 | -56.41% | ||
| 2017 | +21.90% | ||
| 2016 | +174.87% | ||
| 2015 | -68.27% |
- Stock Market
- Equities
- IVITF Stock
- Quotes Invictus MD Strategies Corp.